{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:16:17Z","timestamp":1778908577508,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      VEXAS syndrome is a recently recognized, acquired monogenic adult onset hemato-inflammatory syndrome characterized by somatic mutations within the\n                      <jats:italic>UBA1<\/jats:italic>\n                      gene. The acronym VEXAS stands for vacuoles, E1 enzyme, X-linked inheritance, autoinflammatory tendencies, and somatic mutations. It presents as a severe progressive disease displaying varied characteristics that bridge hematologic and rheumatologic domains. Herein, we describe a series with a detailed evaluation of 11 cases of VEXAS syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A comprehensive retrospective analysis of patients diagnosed with VEXAS syndrome over the last 5 years (2020\u20132025) was conducted. Data on clinical presentation, histopathological findings, genetic characteristics, and outcomes were recorded for systematic characterization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 11 cases of VEXAS syndrome were identified. All the patients were males with an age range from 42 to 77 years. Prominent clinical characteristics included history of fever (11), arthritis\/arthralgia (10), inflammatory skin lesions (7), vasculitis (6), ocular inflammatory conditions (6), relapsing polychondritis (6), unprovoked venous thrombosis (5), and auricular chondritis (4). Persistent unexplained cytopenia was present in all the patients, manifesting as anemia (10, 8 of which were macrocytic), thrombocytopenia (4), and neutropenia (2). Bone marrow examination was performed in nine cases, five showed morphologic dysplasia. Furthermore, all nine cases characteristically showed cytoplasmic vacuolations in hematopoietic precursors. UBA1 somatic mutations included p.Met41Thr (c.122 T&gt;C Exon 3) (55%), p.Met41Val (c.121 A&gt;G Exon 3) (27%), p.Met41Leu (c.121 A&gt;C Exon 3) (9%), and a variant in the acceptor splice site of Exon 3 (c.118 G&gt;C) (9%). p.Met41Val is associated with inferior overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study characterizes the clinical, morphologic, and laboratory features of VEXAS syndrome and presents the first comprehensive patient cohort from India. With a complex and heterogeneous clinical profile, awareness of the disease is particularly essential among hematologists, rheumatologists, and dermatologists for accurate diagnosis and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12308-026-00695-5","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:22:23Z","timestamp":1778901743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["VEXAS syndrome: a comprehensive clinicopathologic and genetic analysis of a predominantly Indian cohort"],"prefix":"10.1007","volume":"19","author":[{"given":"Dheeraj","family":"Chinnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aadya","family":"Kerkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prateek","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreejesh","family":"Sreedharanunni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayanan","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramya","family":"Puligari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha Avtarkrishan","family":"Ganju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakashini","family":"Mruthyunjaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lekshmon","family":"K.S.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Bishnoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipanker","family":"De","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarath Chandra Mouli","family":"Veeravalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishvdeep","family":"Khushoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avtar Krishan","family":"Ganju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanta","family":"Padhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Antony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arushi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dikshat Gopal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"27","key":"695_CR1","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W et al (2020) Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med 383(27):2628\u20132638","journal-title":"N Engl J Med"},{"issue":"3","key":"695_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E et al (2022) Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol 186(3):564\u2013574","journal-title":"Br J Dermatol"},{"issue":"26","key":"695_CR3","first-page":"3591","volume":"137","author":"PC Grayson","year":"2021","unstructured":"Grayson PC, Patel BA, Young NS (2021) VEXAS syndrome. Blood 137(26):3591\u20133594","journal-title":"Blood"},{"issue":"26","key":"695_CR4","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1182\/blood.2020010286","volume":"137","author":"JA Poulter","year":"2021","unstructured":"Poulter JA, Collins JC, Cargo C, De Tute RM, Evans P, Ospina Cardona D et al (2021) Novel somatic mutations in UBA1 as a cause of VEXAS syndrome. Blood 137(26):3676\u20133681","journal-title":"Blood"},{"issue":"2","key":"695_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/1744666X.2023.2157262","volume":"19","author":"A Al-Hakim","year":"2023","unstructured":"Al-Hakim A, Savic S (2023) An update on VEXAS syndrome. Expert Rev Clin Immunol 19(2):203\u2013215","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"695_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11739-023-03193-z","volume":"18","author":"A Vitale","year":"2023","unstructured":"Vitale A, Caggiano V, Bimonte A, Caroni F, Tosi GM, Fabbiani A et al (2023) VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases. Intern Emerg Med 18(3):711\u2013722","journal-title":"Intern Emerg Med"},{"issue":"4","key":"695_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/qjmed\/hcac259","volume":"116","author":"A Varadarajan","year":"2023","unstructured":"Varadarajan A, Verghese RM, Tirlangi PK, Dass J, Soneja M, Seth T (2023) VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic). QJM Int J Med 116(4):313\u2013315","journal-title":"QJM Int J Med"},{"issue":"12","key":"695_CR8","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1093\/rheumatology\/keab524","volume":"60","author":"M Templ\u00e9","year":"2021","unstructured":"Templ\u00e9 M, Duroyon E, Croizier C, Rossignol J, Huet T, Friedrich C et al (2021) Atypical splice-site mutations causing VEXAS syndrome. Rheumatol Oxf Engl 60(12):e435\u2013e437","journal-title":"Rheumatol Oxf Engl"},{"issue":"4","key":"695_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jama.2022.24836","volume":"329","author":"DB Beck","year":"2023","unstructured":"Beck DB, Bodian DL, Shah V, Mirshahi UL, Kim J, Ding Y et al (2023) Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population. JAMA 329(4):318\u2013324","journal-title":"JAMA"},{"issue":"Suppl 1","key":"695_CR10","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/annrheumdis-2023-eular.1773","volume":"82","author":"M Ford","year":"2023","unstructured":"Ford M, Khan T (2023) Pos1580 a Case Series of Vexas Syndrome Identified in the West Midlands. United Kingdom Ann Rheum Dis 82(Suppl 1):1166\u20131167","journal-title":"United Kingdom Ann Rheum Dis"},{"issue":"4","key":"695_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/j.seminhematol.2021.10.005","volume":"58","author":"BA Patel","year":"2021","unstructured":"Patel BA, Ferrada MA, Grayson PC, Beck DB (2021) VEXAS syndrome: an inflammatory and hematologic disease. Semin Hematol 58(4):201\u2013203","journal-title":"Semin Hematol"},{"issue":"16","key":"695_CR12","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","volume":"5","author":"IE Obiorah","year":"2021","unstructured":"Obiorah IE, Patel BA, Groarke EM, Wang W, Trick M, Ombrello AK et al (2021) Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv 5(16):3203\u20133215","journal-title":"Blood Adv"},{"issue":"4","key":"695_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/j.seminhematol.2021.10.006","volume":"58","author":"EM Groarke","year":"2021","unstructured":"Groarke EM, Dulau-Florea AE, Kanthi Y (2021) Thrombotic manifestations of VEXAS syndrome. Semin Hematol 58(4):230\u2013238","journal-title":"Semin Hematol"},{"issue":"4","key":"695_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/art.41992","volume":"74","author":"F Muratore","year":"2022","unstructured":"Muratore F, Marvisi C, Castrignan\u00f2 P, Nicoli D, Farnetti E, Bonanno O et al (2022) VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis. Arthritis Rheumatol Hoboken 74(4):665\u2013670","journal-title":"Arthritis Rheumatol Hoboken"},{"issue":"10","key":"695_CR15","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1016\/j.mayocp.2021.06.006","volume":"96","author":"MJ Koster","year":"2021","unstructured":"Koster MJ, Kourelis T, Reichard KK, Kermani TA, Beck DB, Cardona DO et al (2021) Clinical heterogeneity of the VEXAS syndrome: a case series. Mayo Clin Proc 96(10):2653\u20139","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"695_CR16","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1093\/rheumatology\/kead506","volume":"63","author":"BE S\u00e1nchez-Hern\u00e1ndez","year":"2024","unstructured":"S\u00e1nchez-Hern\u00e1ndez BE, Calder\u00f3n-Espinoza I, Mart\u00edn-Nares E (2024) Challenging the paradigm: a case of early-onset VEXAS syndrome. Rheumatology 63(3):e99-100","journal-title":"Rheumatology"},{"issue":"6","key":"695_CR17","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1093\/rheumatology\/keae619","volume":"64","author":"V Lacombe","year":"2025","unstructured":"Lacombe V, Echerbault R, Bourguiba R, Georgin-Lavialle S (2025) Comment on: Comparing clinical features between males and females with VEXAS syndrome: data from literature analysis of patient reports: Reply. Rheumatology 64(6):4091\u20134092","journal-title":"Rheumatology"},{"issue":"4","key":"695_CR18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3324\/haematol.2021.280238","volume":"107","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins RJ, McGinnis E, Johal B, Chen LY, Wilson L, Cardona DO et al (2022) VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome). Haematologica 107(4):1011\u20131013","journal-title":"Haematologica"},{"issue":"2","key":"695_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.41957","volume":"74","author":"A Sharma","year":"2022","unstructured":"Sharma A, Naidu G, Deo P, Beck DB (2022) VEXAS syndrome with Systemic Lupus Erythematosus- expanding the spectrum of associated conditions. Arthritis Rheumatol Hoboken 74(2):369\u2013371","journal-title":"Arthritis Rheumatol Hoboken"},{"issue":"7","key":"695_CR20","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/diagnostics12071590","volume":"12","author":"M Templ\u00e9","year":"2022","unstructured":"Templ\u00e9 M, Kosmider O (2022) VEXAS Syndrome: A Novelty in MDS Landscape. Diagnostics 12(7):1590","journal-title":"Diagnostics"},{"issue":"7","key":"695_CR21","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1007\/s10875-021-01070-y","volume":"41","author":"A Grey","year":"2021","unstructured":"Grey A, Cheong PL, Lee FJ, Abadir E, Favaloro J, Yang S et al (2021) A Case of VEXAS Syndrome Complicated by Hemophagocytic Lymphohistiocytosis. J Clin Immunol 41(7):1648\u20131651","journal-title":"J Clin Immunol"},{"key":"695_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2021.102636","volume":"93","author":"RL Kao","year":"2022","unstructured":"Kao RL, Jacobsen AA, Billington CJ, Yohe SL, Beckman AK, Vercellotti GM et al (2022) A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis. Blood Cells Mol Dis 93:102636","journal-title":"Blood Cells Mol Dis"},{"key":"695_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.897722","volume":"13","author":"H Matsumoto","year":"2022","unstructured":"Matsumoto H, Fujita Y, Fukatsu M, Ikezoe T, Yokose K, Asano T et al (2022) Case report: coexistence of multiple myeloma and auricular chondritis in VEXAS syndrome. Front Immunol 13:897722","journal-title":"Front Immunol"},{"issue":"3","key":"695_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1182\/blood.2023020772","volume":"142","author":"L Malcovati","year":"2023","unstructured":"Malcovati L (2023) VEXAS: walking on the edge of malignancy. Blood 142(3):214\u2013215","journal-title":"Blood"},{"issue":"3","key":"695_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15050","volume":"33","author":"AJ Saad","year":"2024","unstructured":"Saad AJ, Patil MK, Cruz N, Lam CS, O\u2019Brien C, Nambudiri VE (2024) VEXAS syndrome: a review of cutaneous findings and treatments in an emerging autoinflammatory disease. Exp Dermatol 33(3):e15050","journal-title":"Exp Dermatol"},{"issue":"1","key":"695_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2023.100242","volume":"4","author":"LT Nicholson","year":"2023","unstructured":"Nicholson LT, Cowen EW, Beck D, Ferrada M, Madigan LM (2023) VEXAS Syndrome\u2014Diagnostic Clues for the Dermatologist and Gaps in Our Current Understanding: A Narrative Review. JID Innov 4(1):100242","journal-title":"JID Innov"},{"issue":"7","key":"695_CR27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/ijd.16635","volume":"62","author":"AS Hines","year":"2023","unstructured":"Hines AS, Mohandesi NA, Lehman JS, Koster MJ, Cantwell HM, Alavi A et al (2023) Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings. Int J Dermatol 62(7):938\u201345","journal-title":"Int J Dermatol"},{"issue":"8","key":"695_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/jamadermatol.2024.1657","volume":"160","author":"IJ Tan","year":"2024","unstructured":"Tan IJ, Ferrada MA, Ahmad S, Fike A, Quinn KA, Groarke EM et al (2024) Skin Manifestations of VEXAS Syndrome and Associated Genotypes. JAMA Dermatol 160(8):822\u2013829","journal-title":"JAMA Dermatol"},{"issue":"13","key":"695_CR29","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1182\/blood.2022016985","volume":"140","author":"MA Ferrada","year":"2022","unstructured":"Ferrada MA, Savic S, Cardona DO, Collins JC, Alessi H, Gutierrez-Rodrigues F et al (2022) Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood 140(13):1496\u20131506","journal-title":"Blood"},{"issue":"9","key":"695_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.983939","volume":"15","author":"R Watanabe","year":"2022","unstructured":"Watanabe R, Kiji M, Hashimoto M (2022) Vasculitis associated with VEXAS syndrome: A literature review. Front Med 15(9):983939","journal-title":"Front Med"},{"issue":"8","key":"695_CR31","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s11739-024-03763-9","volume":"19","author":"R Bixio","year":"2024","unstructured":"Bixio R, Bindoli S, Morciano A, Padoan R, Aldegheri F, Mastropaolo F et al (2024) The role of 18FDG\u2013PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature. Intern Emerg Med 19(8):2331\u201345","journal-title":"Intern Emerg Med"},{"issue":"26","key":"695_CR32","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1182\/blood.2020010177","volume":"137","author":"E Bourbon","year":"2021","unstructured":"Bourbon E, Heiblig M, Gerfaud Valentin M, Barba T, Durel CA, Lega JC et al (2021) Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood 137(26):3682\u20133684","journal-title":"Blood"},{"issue":"2","key":"695_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002255","volume":"8","author":"MY Khitri","year":"2022","unstructured":"Khitri MY, Guedon AF, Georgin-Lavialle S, Terrier B, Saadoun D, Seguier J et al (2022) Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients. RMD Open 8(2):e002255","journal-title":"RMD Open"},{"issue":"6","key":"695_CR34","first-page":"1432","volume":"110","author":"LP Zhao","year":"2025","unstructured":"Zhao LP, Jachiet V, Kosmider O, Larcher L, Clappier E, S\u00e9bert M et al (2025) Very long-term remission with azacitidine in VEXAS syndrome. Haematologica 110(6):1432\u20131435","journal-title":"Haematologica"},{"issue":"8","key":"695_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.129","volume":"8","author":"AM Aalbers","year":"2024","unstructured":"Aalbers AM, van Daele PLA, Dalm VASH, Valk PJM, Raaijmakers MHGP (2024) Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome. HemaSphere 8(8):e129","journal-title":"HemaSphere"},{"issue":"Supplement 1","key":"695_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1182\/blood-2023-174385","volume":"142","author":"C Gurnari","year":"2023","unstructured":"Gurnari C, Koster L, Baaij L, Heiblig M, Yakoub-Agha I, Passweg JR et al (2023) Allogeneic Hematopoietic Cell Transplantation for Vexas Syndrome: Results of a Multicenter Study from the Chronic Malignancies and Autoimmune Disease Working Parties of the EBMT. Blood 142(Supplement 1):708","journal-title":"Blood"},{"issue":"2","key":"695_CR37","first-page":"S151","volume":"30","author":"M Shahazad","year":"2024","unstructured":"Shahazad M, Mir WA, Khalid MF, Abbas S, Anwar I, Amin MK et al (2024) Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Vexas Syndrome: A Systematic Review and Meta-Analysis. Transplant Cell Ther Off Publ Am Soc Transplant Cell Ther 30(2):S151\u2013S152","journal-title":"Transplant Cell Ther Off Publ Am Soc Transplant Cell Ther"},{"issue":"7","key":"695_CR38","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1016\/S2665-9913(25)00034-7","volume":"7","author":"A Al-Hakim","year":"2025","unstructured":"Al-Hakim A, Trikha R, Htut EEP, Chowdhury O, MacLennan CA, Chee A et al (2025) Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study. Lancet Rheumatol 7(7):e472\u2013e484","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"695_CR39","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s10067-024-07160-7","volume":"43","author":"SB Ali","year":"2024","unstructured":"Ali SB, Gurnari C (2024) Allogenic haematopoietic stem cell transplantation in VEXAS: a review of 33 patients. Clin Rheumatol 43(11):3565\u20133575","journal-title":"Clin Rheumatol"},{"issue":"4","key":"695_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/ijd.16991","volume":"63","author":"D De","year":"2024","unstructured":"De D, Baskaran N, Shah S, Bishnoi A, Bhatia P, Sharma P et al (2024) Cutaneous manifestations of VEXAS syndrome: multiple changing faces in the same patient. Int J Dermatol 63(4):517\u201320","journal-title":"Int J Dermatol"},{"issue":"2","key":"695_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.41957","volume":"74","author":"A Sharma","year":"2022","unstructured":"Sharma A, Naidu G, Deo P, Beck DB (2022) VEXAS syndrome with systemic lupus erythematosus: expanding the spectrum of associated conditions. Arthritis Rheumatol 74(2):369\u201371","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"695_CR42","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","volume":"149","author":"CI van der Made","year":"2022","unstructured":"van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL et al (2022) Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of patients with VEXAS. J Allergy Clin Immunol 149(1):432-439.e4","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"695_CR43","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","volume":"80","author":"N Tsuchida","year":"2021","unstructured":"Tsuchida N, Kunishita Y, Uchiyama Y, Kirino Y, Enaka M, Yamaguchi Y et al (2021) Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Ann Rheum Dis 80(8):1057\u201361","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00695-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00695-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00695-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:02:54Z","timestamp":1778907774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00695-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00695-5","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Review Board, protocol 26761.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The IRB determined this research is exempt under Category 4(iii). A waiver of authorization criteria was satisfied in accordance with 45 CFR 164.512(i)(2)(ii).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The IRB determined this research is exempt under Category 4(iii). A waiver of authorization was approved in accordance with 45 CFR 164.512(i).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"21"}}